High Outlier
Strength
24 ug/1
Manufacturer
SpecGx LLCNDC
23635052460
Classification
Brand
Dosage Form
CAPSULE, GELATIN COATED
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
LUBIPROSTONEApproval Type
New Drug (NDA)
FDA Application
NDA021908On Market Since
4/1/2024
Pharmacological Classes
Chloride Channel Activator
Chloride Channel Activators
Related Drugs
Same classification
No related drugs found.